Table of Contents 1 Polio Vaccine Market Overview 1.1 Product Overview and Scope of Polio Vaccine 1.2 Polio Vaccine Segment by Type 1.2.1 Global Polio Vaccine Sales Growth Rate Comparison by Type (2021-2026) 1.2.2 Inactivated Polio Vaccine (IPV) 1.2.3 Oral Polio Vaccine (OPV) 1.3 Polio Vaccine Segment by Application 1.3.1 Polio Vaccine Sales Comparison by Application: 2020 VS 2026 1.3.2 Public 1.3.3 Private 1.4 Global Polio Vaccine Market Size Estimates and Forecasts 1.4.1 Global Polio Vaccine Revenue 2015-2026 1.4.2 Global Polio Vaccine Sales 2015-2026 1.4.3 Polio Vaccine Market Size by Region: 2020 Versus 2026 2 Global Polio Vaccine Market Competition by Manufacturers 2.1 Global Polio Vaccine Sales Market Share by Manufacturers (2015-2020) 2.2 Global Polio Vaccine Revenue Share by Manufacturers (2015-2020) 2.3 Global Polio Vaccine Average Price by Manufacturers (2015-2020) 2.4 Manufacturers Polio Vaccine Manufacturing Sites, Area Served, Product Type 2.5 Polio Vaccine Market Competitive Situation and Trends 2.5.1 Polio Vaccine Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key Polio Vaccine Players (Opinion Leaders) 3 Polio Vaccine Retrospective Market Scenario by Region 3.1 Global Polio Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global Polio Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America Polio Vaccine Market Facts & Figures by Country 3.3.1 North America Polio Vaccine Sales by Country 3.3.2 North America Polio Vaccine Sales by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Polio Vaccine Market Facts & Figures by Country 3.4.1 Europe Polio Vaccine Sales by Country 3.4.2 Europe Polio Vaccine Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Polio Vaccine Market Facts & Figures by Region 3.5.1 Asia Pacific Polio Vaccine Sales by Region 3.5.2 Asia Pacific Polio Vaccine Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Polio Vaccine Market Facts & Figures by Country 3.6.1 Latin America Polio Vaccine Sales by Country 3.6.2 Latin America Polio Vaccine Sales by Country 3.6.3 Mexico 3.6.3 Brazil 3.6.3 Argentina 3.7 Middle East and Africa Polio Vaccine Market Facts & Figures by Country 3.7.1 Middle East and Africa Polio Vaccine Sales by Country 3.7.2 Middle East and Africa Polio Vaccine Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Polio Vaccine Historic Market Analysis by Type 4.1 Global Polio Vaccine Sales Market Share by Type (2015-2020) 4.2 Global Polio Vaccine Revenue Market Share by Type (2015-2020) 4.3 Global Polio Vaccine Price Market Share by Type (2015-2020) 4.4 Global Polio Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Polio Vaccine Historic Market Analysis by Application 5.1 Global Polio Vaccine Sales Market Share by Application (2015-2020) 5.2 Global Polio Vaccine Revenue Market Share by Application (2015-2020) 5.3 Global Polio Vaccine Price by Application (2015-2020) 6 Company Profiles and Key Figures in Polio Vaccine Business 6.1 Sanofi 6.1.1 Corporation Information 6.1.2 Sanofi Description, Business Overview and Total Revenue 6.1.3 Sanofi Polio Vaccine Sales, Revenue and Gross Margin (2015-2020) 6.1.4 Sanofi Products Offered 6.1.5 Sanofi Recent Development 6.2 GSK 6.2.1 GSK Polio Vaccine Production Sites and Area Served 6.2.2 GSK Description, Business Overview and Total Revenue 6.2.3 GSK Polio Vaccine Sales, Revenue and Gross Margin (2015-2020) 6.2.4 GSK Products Offered 6.2.5 GSK Recent Development 6.3 Bibcol 6.3.1 Bibcol Polio Vaccine Production Sites and Area Served 6.3.2 Bibcol Description, Business Overview and Total Revenue 6.3.3 Bibcol Polio Vaccine Sales, Revenue and Gross Margin (2015-2020) 6.3.4 Bibcol Products Offered 6.3.5 Bibcol Recent Development 6.4 Serum Institute 6.4.1 Serum Institute Polio Vaccine Production Sites and Area Served 6.4.2 Serum Institute Description, Business Overview and Total Revenue 6.4.3 Serum Institute Polio Vaccine Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Serum Institute Products Offered 6.4.5 Serum Institute Recent Development 6.5 Tiantan Biological 6.5.1 Tiantan Biological Polio Vaccine Production Sites and Area Served 6.5.2 Tiantan Biological Description, Business Overview and Total Revenue 6.5.3 Tiantan Biological Polio Vaccine Sales, Revenue and Gross Margin (2015-2020) 6.5.4 Tiantan Biological Products Offered 6.5.5 Tiantan Biological Recent Development 6.6 IMBCA 6.6.1 IMBCA Polio Vaccine Production Sites and Area Served 6.6.2 IMBCA Description, Business Overview and Total Revenue 6.6.3 IMBCA Polio Vaccine Sales, Revenue and Gross Margin (2015-2020) 6.6.4 IMBCA Products Offered 6.6.5 IMBCA Recent Development 6.7 Panacea Biotec Ltd 6.6.1 Panacea Biotec Ltd Polio Vaccine Production Sites and Area Served 6.6.2 Panacea Biotec Ltd Description, Business Overview and Total Revenue 6.6.3 Panacea Biotec Ltd Polio Vaccine Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Panacea Biotec Ltd Products Offered 6.7.5 Panacea Biotec Ltd Recent Development 6.8 Bio-Med 6.8.1 Bio-Med Polio Vaccine Production Sites and Area Served 6.8.2 Bio-Med Description, Business Overview and Total Revenue 6.8.3 Bio-Med Polio Vaccine Sales, Revenue and Gross Margin (2015-2020) 6.8.4 Bio-Med Products Offered 6.8.5 Bio-Med Recent Development 6.9 Halfkin Bio-Pharmaceuticals 6.9.1 Halfkin Bio-Pharmaceuticals Polio Vaccine Production Sites and Area Served 6.9.2 Halfkin Bio-Pharmaceuticals Description, Business Overview and Total Revenue 6.9.3 Halfkin Bio-Pharmaceuticals Polio Vaccine Sales, Revenue and Gross Margin (2015-2020) 6.9.4 Halfkin Bio-Pharmaceuticals Products Offered 6.9.5 Halfkin Bio-Pharmaceuticals Recent Development 7 Polio Vaccine Manufacturing Cost Analysis 7.1 Polio Vaccine Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Polio Vaccine 7.4 Polio Vaccine Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Polio Vaccine Distributors List 8.3 Polio Vaccine Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global Polio Vaccine Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Polio Vaccine by Type (2021-2026) 10.1.2 Global Forecasted Revenue of Polio Vaccine by Type (2021-2026) 10.2 Polio Vaccine Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Polio Vaccine by Application (2021-2026) 10.2.2 Global Forecasted Revenue of Polio Vaccine by Application (2021-2026) 10.3 Polio Vaccine Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Polio Vaccine by Region (2021-2026) 10.3.2 Global Forecasted Revenue of Polio Vaccine by Region (2021-2026) 10.4 North America Polio Vaccine Estimates and Projections (2021-2026) 10.5 Europe Polio Vaccine Estimates and Projections (2021-2026) 10.6 Asia Pacific Polio Vaccine Estimates and Projections (2021-2026) 10.7 Latin America Polio Vaccine Estimates and Projections (2021-2026) 10.8 Middle East and Africa Polio Vaccine Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Polio Vaccine Sales (M Doses) Growth Rate Comparison by Type (2015-2026) Table 2. Global Polio Vaccine Sales (M Doses) Comparison by Application: 2020 VS 2026 Table 3. Global Polio Vaccine Market Size by Type (M Doses) (US$ Million) (2020 VS 2026) Table 4. Global Key Polio Vaccine Manufacturers Covered in This Study Table 5. Global Polio Vaccine Sales (M Doses) by Manufacturers (2015-2020) Table 6. Global Polio Vaccine Sales Share by Manufacturers (2015-2020) Table 7. Global Polio Vaccine Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Polio Vaccine Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Polio Vaccine Average Price (USD/K Doses) of Key Manufacturers (2015-2020) Table 10. Manufacturers Polio Vaccine Sales Sites and Area Served Table 11. Manufacturers Polio Vaccine Product Types Table 12. Global Polio Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Polio Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Polio Vaccine as of 2019) Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Polio Vaccine Players Table 16. Global Polio Vaccine Sales (M Doses) by Region (2015-2020) Table 17. Global Polio Vaccine Sales Market Share by Region (2015-2020) Table 18. Global Polio Vaccine Revenue (Million US$) by Region (2015-2020) Table 19. Global Polio Vaccine Revenue Market Share by Region (2015-2020) Table 20. North America Polio Vaccine Sales by Country (2015-2020) (M Doses) Table 21. North America Polio Vaccine Sales Market Share by Country (2015-2020) Table 22. North America Polio Vaccine Revenue by Country (2015-2020) (US$ Million) Table 23. North America Polio Vaccine Revenue Market Share by Country (2015-2020) Table 24. Europe Polio Vaccine Sales by Country (2015-2020) (M Doses) Table 25. Europe Polio Vaccine Sales Market Share by Country (2015-2020) Table 26. Europe Polio Vaccine Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Polio Vaccine Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Polio Vaccine Sales by Region (2015-2020) (M Doses) Table 29. Asia Pacific Polio Vaccine Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Polio Vaccine Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Polio Vaccine Revenue Market Share by Region (2015-2020) Table 32. Latin America Polio Vaccine Sales by Country (2015-2020) (M Doses) Table 33. Latin America Polio Vaccine Sales Market Share by Country (2015-2020) Table 34. Latin America Polio Vaccine Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Polio Vaccine Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Polio Vaccine Sales by Country (2015-2020) (M Doses) Table 37. Middle East and Africa Polio Vaccine Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Polio Vaccine Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Polio Vaccine Revenue Market Share by Country (2015-2020) Table 40. Global Polio Vaccine Sales (M Doses) by Type (2015-2020) Table 41. Global Polio Vaccine Sales Share by Type (2015-2020) Table 42. Global Polio Vaccine Revenue (Million US$) by Type (2015-2020) Table 43. Global Polio Vaccine Revenue Share by Type (2015-2020) Table 44. Global Polio Vaccine Price (USD/K Doses) by Type (2015-2020) Table 45. Global Polio Vaccine Sales (M Doses) by Application (2015-2020) Table 46. Global Polio Vaccine Sales Market Share by Application (2015-2020) Table 47. Global Polio Vaccine Sales Growth Rate by Application (2015-2020) Table 48. Sanofi Polio Vaccine Corporation Information Table 49. Sanofi Description and Business Overview Table 50. Sanofi Polio Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020) Table 51. Sanofi Main Product Table 52. Sanofi Recent Development Table 53. GSK Polio Vaccine Corporation Information Table 54. GSK Corporation Information Table 55. GSK Polio Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020) Table 56. GSK Main Product Table 57. GSK Recent Development Table 58. Bibcol Polio Vaccine Corporation Information Table 59. Bibcol Corporation Information Table 60. Bibcol Polio Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020) Table 61. Bibcol Main Product Table 62. Bibcol Recent Development Table 63. Serum Institute Polio Vaccine Corporation Information Table 64. Serum Institute Corporation Information Table 65. Serum Institute Polio Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020) Table 66. Serum Institute Main Product Table 67. Serum Institute Recent Development Table 68. Tiantan Biological Polio Vaccine Corporation Information Table 69. Tiantan Biological Corporation Information Table 70. Tiantan Biological Polio Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020) Table 71. Tiantan Biological Main Product Table 72. Tiantan Biological Recent Development Table 73. IMBCA Polio Vaccine Corporation Information Table 74. IMBCA Corporation Information Table 75. IMBCA Polio Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020) Table 76. IMBCA Main Product Table 77. IMBCA Recent Development Table 78. Panacea Biotec Ltd Polio Vaccine Corporation Information Table 79. Panacea Biotec Ltd Corporation Information Table 80. Panacea Biotec Ltd Polio Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020) Table 81. Panacea Biotec Ltd Main Product Table 82. Panacea Biotec Ltd Recent Development Table 83. Bio-Med Polio Vaccine Corporation Information Table 84. Bio-Med Corporation Information Table 85. Bio-Med Polio Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020) Table 86. Bio-Med Main Product Table 87. Bio-Med Recent Development Table 88. Halfkin Bio-Pharmaceuticals Polio Vaccine Corporation Information Table 89. Halfkin Bio-Pharmaceuticals Corporation Information Table 90. Halfkin Bio-Pharmaceuticals Polio Vaccine Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020) Table 91. Halfkin Bio-Pharmaceuticals Main Product Table 92. Halfkin Bio-Pharmaceuticals Recent Development Table 93. Sales Base and Market Concentration Rate of Raw Material Table 94. Key Suppliers of Raw Materials Table 95. Polio Vaccine Distributors List Table 96. Polio Vaccine Customers List Table 97. Market Key Trends Table 98. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 99. Key Challenges Table 100. Global Polio Vaccine Sales (M Doses) Forecast by Type (2021-2026) Table 101. Global Polio Vaccine Sales Market Share Forecast by Type (2021-2026) Table 102. Global Polio Vaccine Revenue (Million US$) Forecast by Type (2021-2026) Table 103. Global Polio Vaccine Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 104. Global Polio Vaccine Sales (M Doses) Forecast by Application (2021-2026) Table 105. Global Polio Vaccine Revenue (Million US$) Forecast by Application (2021-2026) Table 106. Global Polio Vaccine Sales (M Doses) Forecast by Region (2021-2026) Table 107. Global Polio Vaccine Sales Market Share Forecast by Region (2021-2026) Table 108. Global Polio Vaccine Revenue Forecast by Region (2021-2026) (US$ Million) Table 109. Global Polio Vaccine Revenue Market Share Forecast by Region (2021-2026) Table 110. Research Programs/Design for This Report Table 111. Key Data Information from Secondary Sources Table 112. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Polio Vaccine Figure 2. Global Polio Vaccine Sales Market Share by Type: 2020 VS 2026 Figure 3. Inactivated Polio Vaccine (IPV) Product Picture Figure 4. Oral Polio Vaccine (OPV) Product Picture Figure 5. Global Polio Vaccine Consumption Market Share by Application: 2020 VS 2026 Figure 6. Public Figure 7. Private Figure 8. Global Polio Vaccine Market Size 2015-2026 (US$ Million) Figure 9. Global Polio Vaccine Sales Capacity (M Doses) (2015-2026) Figure 10. Global Polio Vaccine Market Size Market Share by Region: 2020 Versus 2026 Figure 11. Polio Vaccine Sales Share by Manufacturers in 2020 Figure 12. Global Polio Vaccine Revenue Share by Manufacturers in 2019 Figure 13. The Global 5 and 10 Largest Players: Market Share by Polio Vaccine Revenue in 2019 Figure 14. Polio Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 15. Global Polio Vaccine Sales Market Share by Region (2015-2020) Figure 16. Global Polio Vaccine Sales Market Share by Region in 2019 Figure 17. Global Polio Vaccine Revenue Market Share by Region (2015-2020) Figure 18. Global Polio Vaccine Revenue Market Share by Region in 2019 Figure 19. North America Polio Vaccine Sales Market Share by Country in 2019 Figure 20. North America Polio Vaccine Revenue Market Share by Country in 2019 Figure 21. U.S. Polio Vaccine Sales Growth Rate (2015-2020) (M Doses) Figure 22. U.S. Polio Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 23. Canada Polio Vaccine Sales Growth Rate (2015-2020) (M Doses) Figure 24. Canada Polio Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 25. Europe Polio Vaccine Sales Market Share by Country in 2019 Figure 26. Europe Polio Vaccine Revenue Market Share by Country in 2019 Figure 27. Germany Polio Vaccine Sales Growth Rate (2015-2020) (M Doses) Figure 28. Germany Polio Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 29. France Polio Vaccine Sales Growth Rate (2015-2020) (M Doses) Figure 30. France Polio Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 31. U.K. Polio Vaccine Sales Growth Rate (2015-2020) (M Doses) Figure 32. U.K. Polio Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 33. Italy Polio Vaccine Sales Growth Rate (2015-2020) (M Doses) Figure 34. Italy Polio Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 35. Russia Polio Vaccine Sales Growth Rate (2015-2020) (M Doses) Figure 36. Russia Polio Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 37. Asia Pacific Polio Vaccine Sales Market Share by Region in 2019 Figure 38. Asia Pacific Polio Vaccine Revenue Market Share by Region in 2019 Figure 39. China Polio Vaccine Sales Growth Rate (2015-2020) (M Doses) Figure 40. China Polio Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 41. Japan Polio Vaccine Sales Growth Rate (2015-2020) (M Doses) Figure 42. Japan Polio Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 43. South Korea Polio Vaccine Sales Growth Rate (2015-2020) (M Doses) Figure 44. South Korea Polio Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 45. India Polio Vaccine Sales Growth Rate (2015-2020) (M Doses) Figure 46. India Polio Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 47. Australia Polio Vaccine Sales Growth Rate (2015-2020) (M Doses) Figure 48. Australia Polio Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. Taiwan Polio Vaccine Sales Growth Rate (2015-2020) (M Doses) Figure 50. Taiwan Polio Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. Indonesia Polio Vaccine Sales Growth Rate (2015-2020) (M Doses) Figure 52. Indonesia Polio Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. Thailand Polio Vaccine Sales Growth Rate (2015-2020) (M Doses) Figure 54. Thailand Polio Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Malaysia Polio Vaccine Sales Growth Rate (2015-2020) (M Doses) Figure 56. Malaysia Polio Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Philippines Polio Vaccine Sales Growth Rate (2015-2020) (M Doses) Figure 58. Philippines Polio Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Vietnam Polio Vaccine Sales Growth Rate (2015-2020) (M Doses) Figure 60. Vietnam Polio Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 61. Latin America Polio Vaccine Sales Market Share by Country in 2019 Figure 62. Latin America Polio Vaccine Revenue Market Share by Country in 2019 Figure 63. Mexico Polio Vaccine Sales Growth Rate (2015-2020) (M Doses) Figure 64. Mexico Polio Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 65. Brazil Polio Vaccine Sales Growth Rate (2015-2020) (M Doses) Figure 66. Brazil Polio Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. Argentina Polio Vaccine Sales Growth Rate (2015-2020) (M Doses) Figure 68. Argentina Polio Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. Middle East and Africa Polio Vaccine Sales Market Share by Country in 2019 Figure 70. Middle East and Africa Polio Vaccine Revenue Market Share by Country in 2019 Figure 71. Turkey Polio Vaccine Sales Growth Rate (2015-2020) (M Doses) Figure 72. Turkey Polio Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 73. Saudi Arabia Polio Vaccine Sales Growth Rate (2015-2020) (M Doses) Figure 74. Saudi Arabia Polio Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. U.A.E Polio Vaccine Sales Growth Rate (2015-2020) (M Doses) Figure 76. U.A.E Polio Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. Sales Market Share of Polio Vaccine by Type (2015-2020) Figure 78. Sales Market Share of Polio Vaccine by Type in 2019 Figure 79. Revenue Share of Polio Vaccine by Type (2015-2020) Figure 80. Revenue Market Share of Polio Vaccine by Type in 2019 Figure 81. Global Polio Vaccine Sales Growth by Type (2015-2020) (M Doses) Figure 82. Global Polio Vaccine Sales Market Share by Application (2015-2020) Figure 83. Global Polio Vaccine Sales Market Share by Application in 2019 Figure 84. Global Revenue Share of Polio Vaccine by Application (2015-2020) Figure 85. Global Revenue Share of Polio Vaccine by Application in 2020 Figure 86. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018 Figure 87. GSK Total Revenue (US$ Million): 2019 Compared with 2018 Figure 88. Bibcol Total Revenue (US$ Million): 2019 Compared with 2018 Figure 89. Serum Institute Total Revenue (US$ Million): 2019 Compared with 2018 Figure 90. Tiantan Biological Total Revenue (US$ Million): 2019 Compared with 2018 Figure 91. IMBCA Total Revenue (US$ Million): 2019 Compared with 2018 Figure 92. Panacea Biotec Ltd Total Revenue (US$ Million): 2019 Compared with 2018 Figure 93. Bio-Med Total Revenue (US$ Million): 2019 Compared with 2018 Figure 94. Halfkin Bio-Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 95. Price Trend of Key Raw Materials Figure 96. Manufacturing Cost Structure of Polio Vaccine Figure 97. Manufacturing Process Analysis of Polio Vaccine Figure 98. Polio Vaccine Industrial Chain Analysis Figure 99. Channels of Distribution Figure 100. Distributors Profiles Figure 101. Porter's Five Forces Analysis Figure 102. North America Polio Vaccine Sales (M Doses) and Growth Rate Forecast (2021-2026) Figure 103. North America Polio Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 104. Europe Polio Vaccine Sales (M Doses) and Growth Rate Forecast (2021-2026) Figure 105. Europe Polio Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 106. Latin America Polio Vaccine Sales (M Doses) and Growth Rate Forecast (2021-2026) Figure 107. Latin America Polio Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 108. Middle East and Africa Polio Vaccine Sales (M Doses) and Growth Rate Forecast (2021-2026) Figure 109. Middle East and Africa Polio Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 110. Asia Pacific Polio Vaccine Sales (M Doses) and Growth Rate Forecast (2021-2026) Figure 111. Asia Pacific Polio Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 112. Bottom-up and Top-down Approaches for This Report Figure 113. Data Triangulation Figure 114. Key Executives Interviewed

Sanofi GSK Bibcol Serum Institute Tiantan Biological IMBCA Panacea Biotec Ltd Bio-Med Halfkin Bio-Pharmaceuticals